| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |